Cell Counting Market

Global Cell Counting Market is valued at USD 10.25 Billion in 2020 and is expected to reach USD 16.25 Billion by 2027 with a CAGR of 6.8% over the forecast period. 

Global Cell Counting Market: Global Size, Trends, Competitive, Historical &Forecast Analysis, 2021-2027- Increasing prevalence of AIDS and cancer, rising government investment for cell-based research and growing development of enhanced informatics solution & improved image analysis instruments are some of the major factors anticipated to drive the growth of Global Cell Counting Market.

Scope of Global Cell Counting Market Report:

Cell counting is a strategy which was utilized for counting of the cells or micelles that are normally suspended in blood or other body fluids. Cell counters assume an important part in deciding the concentration of platelets, the presence of microorganisms, the harmful impact of specific drugs on model cells, and some more. The number of cells is communicated as the number of cells per unit volume in a fluid medium. Different methodologies in medicine and biology need the counting of cells. Diagnosis and treatment of diseases can be carried out by cell counting. Cell counting helps to classify cell types and detection of disease through probes by which doctors can develop a better treatment for patient.

By using cell counting, counting or quantifying the cells is carried out. With the use of this method, concentration and viability of cells is determined. There are various sorts of methods present for counting of cells such as; counting chambers, by plating and calculating colony forming unit, or by automation, which incorporates electrical resistance mechanism, flow cytometer, image analysis, and stereo logic cell counting. By the counting of cells in a known little volume, the fixation can be mediated. Cell counting is quite possibly the most commonly performed analytic and research labs in biotechnology, medicine, and pharmacy. Cells can be counted in manual or programmed cell counters. Computerized cell counters are intended to take care of the issues of manual cell counting.

During COVID-19 pandemic, the counting instruments store network had been upset because of the prohibition on transportation. The cell counting exercises was been disturbed owing to the tough government rules. However, major biopharmaceutical organizations and clinical foundations have been working toward recognizing the infection genome and what it means for the human body. Hardly any tests have shown that a few patients with COVID-19 have higher white blood cell and neutrophil levels and lower lymphocyte creation. Also, the neutrophil-to-lymphocyte proportion can be utilized as a biomarker to anticipate the result of a disease.

Key Players for Global Cell Counting Market Report:

Some major key players for global cell counting market report cover prominent players like Nexcelom Bioscience LLC, Abbott, Corning Incorporated, Dickinson and Company, Tecan Trading AG, Danaher Corporation, Tip Biosystems, Becton, PerkinElmer Inc, Logos Biosystems Inc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Siemens Healthcare Private Limited, Merck KGaA, Sysmex Corporation, Cole-Parmer Instrument Company LLC, Olympus Corporation and others.

Global Cell Counting Market Segmentation:

Global cell counting market is segmented on the basis of product, application, and region & country level. Based upon product, cell counting market is classified into consumables & accessories and instruments. The consumables & accessories is further sub-divided into spectrophotometers, flow cytometers, hemocytometers, automated cell counters and others. The instruments is further sub-divided into reagents, microplates and others. Based upon application, the market is divided into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and other.

By Product:

• Consumables & Accessories
  • Reagents
  • Microplates
  • Others
• Instruments
  • Spectrophotometers
  • Flow Cytometers
  • Hemocytometers
  • Automated cell counters
  • Others

By End-Users:

• Research Institutes
• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Other

The regions covered in this global cell counting market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of cell counting is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.

Increasing Prevalence of AIDS and Cancer, Rising Government Investment for Cell-Based Research and Growing Development of Enhanced Informatics Solution & Improved Image Analysis Instruments Drive the Market Growth

One of the major factors driving the growth of global cell counting market is increasing prevalence of AIDS and cancer. Cell counting works with the assurance of intra-tumour heterogeneity, which is a crucial process in surveying cancer growth movement in the patient's body. Cell counting helps in the assurance and detection of metastatic tumours, essential tumours, and circulating tumours. For instance; According to the World Health Organization (WHO), from September 2018, disease was answerable for roughly 9.6 million deaths in 2018, making it the subsequent driving reason for death globally. Another report from 2018, around 37.9 million individuals were infected with AIDS with 770,000 deaths across the globe.

In addition, rising government investment for stem cell research is also fostering the market growth. The inspirational perspectives toward stem cell research, upheld further financing, and high general awareness regarding stem cells are also supplementing the market growth. For instance; from 1997 through 2019, the National Natural Science Foundation of China dispensed generally $576 million to 8,050 stem cell programs at Chinese colleges and research institutions. China's yearly distributions on stem cells expanded from under 0.6% of the world's absolute stem cell publications in 1999 to over 14.1% in 2014. Furthermore, growing development of enhanced informatics solution & improved image analysis instruments are also augmenting the market growth.

However, rising number of product recalls of hematology analyzers and huge cost of advanced technology may hamper the global cell counting market growth. In spite of that, increasing demand for cell counting instrument and growing focus on stem cell research can provide various opportunities for the further growth of the global cell counting market.

North America is Expected to Dominate the Global Cell Counting Market

North America is expected to dominate the global cell counting market due to increasing prevalence of chronic diseases like cardiovascular and blood diseases, growing research & development activities and highly developed healthcare infrastructure in this region. For instance; as per the Centers for Disease Control and Prevention (CDC), in 2019, 38,741 individuals got HIV positive in the United States. In 2019, Agilent Technologies bought BioTek Instruments, Inc. Agilent Technologies' essence in the cell counting industry will be reinforced because of this acquisition. BioTek is a world head in the development, assembling, and conveyance of state of the art life science instruments. Cell imaging gadgets, washers, automatic incubators, microplate readers, allocators, and stackers are among the organization's few products.

Asia Pacific is the fastest developing area in global cell counting market due to the increasing number of stem cell based research and improving healthcare facilities in this region. For example; as indicated by the World Bank Group, in 2014, China's medical services use was 5.5% of the GDP, and the country's medical services use is relied upon to double by 2020.

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2027
Market Size in 2020:	USD 10.25 Billion
Base year considered	2020
Forecast Period CAGR %:	6.8%
Market Size Expected in 2027:	USD 16.25 Billion
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	Nexcelom Bioscience LLC, Abbott, Corning Incorporated, Dickinson and Company, Tecan Trading AG, Danaher Corporation, Tip Biosystems, Becton, PerkinElmer Inc, Logos Biosystems Inc, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Siemens Healthcare Private Limited, Merck KGaA, Sysmex Corporation, Cole-Parmer Instrument Company LLC, Olympus Corporation and others.
Segments Covered	By Product, By End Users
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Global Cell Counting Market Report

• Global Cell Counting Market report covers in-depth historical and forecasts analysis.
• Global Cell Counting Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global Cell Counting Market report helps to identify opportunities in the marketplace.
• Global Cell Counting Market report covers an extensive analysis of emerging trends and competitive landscape.

Cell Counting Methods 

• Counting chamber.
• Plating and CFU counting.
• Electrical resistance.
• Flow cytometry.
• Image analysis.
• Stereological cell counting.

Cell Counting Applications

• Medicine Industry
• In cell therapy